Monica_Bertagnolli

Monica Bertagnolli

Monica Bertagnolli

American surgical oncologist (born 1959)


Monica Bertagnolli (born 1959) is an American surgical oncologist and the 17th director of the National Institutes of Health. She previously served as the 16th director of the National Cancer Institute (NCI).[1] Prior to her governmental positions, she worked at Brigham and Women's Hospital and Dana–Farber Cancer Institute and was the Richard E. Wilson Professor of Surgery at Harvard Medical School.[2]

Quick Facts 17th Director of the National Institutes of Health, President ...

She has advocated for inclusion of rural communities in clinical studies and served as Chair of the Alliance for Clinical Trials in Oncology until her appointment to lead the NCI.[3] Bertagnolli specializes in the treatment of tumors from gastrointestinal diseases and soft tissue sarcomas.[4] She is the former President of the American Society of Clinical Oncology and was inducted into the National Academy of Medicine in 2021.[5][6]

Early life and education

Bertagnolli grew up on a cattle ranch in Wyoming.[7] Her parents were first generation French Basque and Italian immigrants.[8][9] She earned a BSE in biochemical engineering from Princeton University.[10][11] She studied medicine at the University of Utah School of Medicine and did her surgical residency at Brigham and Women's Hospital. She became board certified in 1993.[12]

Cancer research

In 1994, Bertagnolli began as an associate surgeon at the Strang Cancer Prevention Center and attending surgeon at NewYork-Presbyterian HospitalCornell.[10] She joined the faculty at Harvard Medical School in 1999 and was appointed at Dana–Farber Cancer Institute in 2000.[10] Bertagnolli specializes in the treatment of tumors from gastrointestinal diseases and is an expert in treating soft-tissue sarcoma.[8] She became the Chief of Surgical Oncology at the Dana–Farber Cancer Institute in 2007, and was the first woman to hold such a position.[8] Bertagnolli's laboratory at the Dana-Farber / Harvard Cancer Center studies the role of Adenomatous polyposis coli (APC) mutations in colorectal carcinogenesis through animal studies and human clinical trials.[13]

Selected publications

Her publications include:

  • Molecular origins of cancer: Molecular basis of colorectal cancer[14]
  • Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention[15]
  • Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq[16]

NIH director

In May 2023, President Biden nominated Bertagnolli to serve as the director of the National Institutes of Health.[17] Dr. Bertagnolli was confirmed by the United States Senate on November 7, 2023. She is the second woman director of the NIH.[18]

Awards and honors

Bertagnolli's awards and honors include:

Personal life

Bertagnolli is married and has two sons.[8] After a routine mammogram, Bertagnolli received an early-stage breast cancer diagnosis in November 2022.[23]


References

  1. "Monica Bertagnolli becomes NCI director - NCI". www.cancer.gov. October 3, 2022. Retrieved October 21, 2022.
  2. Dutchen, Stephanie. "In the Picture". Harvard Medicine magazine. Retrieved October 24, 2021.
  3. "National Academy of Medicine Elects 100 New Members". National Academy of Medicine. October 18, 2021. Retrieved October 24, 2021.
  4. "Women's History Month - Monica Bertagnnolli, MD". AAUW California. March 3, 2018. Retrieved October 24, 2021.
  5. "NCI Director Dr. Monica M. Bertagnolli - NCI". www.cancer.gov. October 3, 2022. Retrieved November 23, 2022.
  6. "Monica M. Bertagnolli, MD, FACS, FASCO". ASCO. Retrieved October 24, 2021.
  7. "Monica M. Bertagnolli, MD - Dana–Farber Cancer Institute | Boston, MA". dana-farber.org. Archived from the original on October 24, 2021. Retrieved October 24, 2021.
  8. "Monica M. Bertagnolli, MD". Dana-Farber / Harvard Cancer Center. Retrieved October 24, 2021.
  9. Solomon SD; McMurray JJ; Pfeffer MA; et al. (March 17, 2005). "Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention". The New England Journal of Medicine. 352 (11): 1071–80. doi:10.1056/NEJMOA050405. ISSN 0028-4793. PMID 15713944. Wikidata Q29620087.
  10. Itay Tirosh; Benjamin Izar; Sanjay M Prakadan; et al. (April 1, 2016). "Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq". Science. 352 (6282): 189–196. doi:10.1126/SCIENCE.AAD0501. ISSN 0036-8075. PMC 4944528. PMID 27124452. Wikidata Q37094024.
  11. Kekatos, Mary (May 15, 2023). "Biden plans to nominate Dr. Monica Bertagnolli at NIH". ABC News. Retrieved May 15, 2023.
  12. Stolberg, Sheryl Gay (November 7, 2023). "Senate Confirms Biden's Pick for N.I.H. Director Over Sanders's Objections". The New York Times. ISSN 0362-4331. Retrieved November 9, 2023.
  13. "Monica Bertagnolli Bio". cancer.org. Retrieved October 24, 2021.
  14. McGinley, Laurie (December 14, 2022). "For new NCI director, work turns personal: She is diagnosed with cancer". The Washington Post. Retrieved December 14, 2022.

Share this article:

This article uses material from the Wikipedia article Monica_Bertagnolli, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.